Rare diseases
Investigational molecules
Locations
Back to Poland15 clinical trials in Leszno, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo
PolandZenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
PolandStudy on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments
PolandStudy on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms
PolandComparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
PolandStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
PolandA study to evaluate the efficacy and safety of orforglipron in patients with peripheral artery disease
PolandA Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress
PolandA Study of Brexanolone Caprilcerbate for Adults with Major Depressive Disorder With or Without Anxious Distress
PolandStudy on ITI-1284 for Patients with Generalized Anxiety Disorder Not Responding to Current Treatment
PolandA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
PolandEvaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Major Depressive Disorder treatments, including studies of new adjunctive therapies for patients with concurrent insomnia symptoms and anhedonia.
These trials aim to enhance treatment outcomes for patients who haven't responded adequately to conventional therapies.
Clinical investigations evaluating new treatment approaches for Generalized Anxiety Disorder, with a focus on developing adjunctive therapies for patients with inadequate response to standard treatments.
Research efforts are directed at improving anxiety symptom management and overall treatment efficacy.
Advanced research into Acute Ischemic Stroke prevention and treatment, including studies of innovative medications for reducing stroke risk in high-risk patients.
These trials focus on developing new therapeutic approaches to prevent recurrent strokes and improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
